Post-hoc analysis from open-label Phase 3 study shows treatment with cenobamate led to a reduction of concomitant anti-seizure medications (ASMs) while maintaining ≥50% and 100% seizure reduction ...

For the first time, clinicians have access to a clear, evidence-based roadmap for adjusting antiseizure medication doses ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

At King Faisal Specialist Hospital & Research Centre (KFSHRC), the treatment of drug-resistant epilepsy has developed over decades into a comprehensive clinical program that combines advanced ...

More than a third of epilepsy medicines in Kenya are of poor quality, a survey in three African countries has revealed. The study shows that most of the poor quality medicines are imported from China ...